dacarbazine and Cancer of Gallbladder

dacarbazine has been researched along with Cancer of Gallbladder in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kitajima, Y; Koga, Y; Kohya, N; Miyazaki, K; Miyoshi, A; Sato, K	1

Other Studies

1 other study(ies) available for dacarbazine and Cancer of Gallbladder

Article	Year
Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest. International journal of oncology, 2005, Volume: 26, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents, Alkylating; Carrier Proteins; Cell Division; Cell Line, Tumor; Dacarbazine; Female; Flow Cytometry; G2 Phase; Gallbladder Neoplasms; Humans; Methylnitrosourea; Mice; Mice, Inbred BALB C; MutL Protein Homolog 1; Neoplasm Proteins; Neoplasms, Experimental; Nuclear Proteins; O(6)-Methylguanine-DNA Methyltransferase; RNA, Messenger	2005

Article

Year

Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest.

International journal of oncology, 2005, Volume: 26, Issue:6

Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents, Alkylating; Carrier Proteins; Cell Division; Cell Line, Tumor; Dacarbazine; Female; Flow Cytometry; G2 Phase; Gallbladder Neoplasms; Humans; Methylnitrosourea; Mice; Mice, Inbred BALB C; MutL Protein Homolog 1; Neoplasm Proteins; Neoplasms, Experimental; Nuclear Proteins; O(6)-Methylguanine-DNA Methyltransferase; RNA, Messenger

2005